TScan Therapeutics Inc. (TCRX)
NASDAQ · Healthcare
TScan Therapeutics Inc. Cash Flow 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -135.3M | -110.8M | -61.4M | -66.5M | -48.7M | -3.0M |
| Depreciation & Amort. | 2.9M | 4.1M | 5.4M | 5.1M | 3.3M | 1.2M |
| Investing Activities | ||||||
| Capital Expenditure | 4.4M | 3.8M | 3.1M | 4.2M | 9.9M | 4.2M |
| Free Cash Flow | -139.7M | -114.6M | -64.5M | -70.7M | -58.6M | -7.3M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
TScan Therapeutics Inc. Cash Flow — FAQ
TScan Therapeutics Inc. (TCRX) cash flow over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRX's cash flow history?
The chart and table above show TScan Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.